Search Results - "Ding, Tomas T."

Regulation of one-carbon metabolism may open new avenues to slow down the initiation and progression of Huntington's disease by Xie, Jiahua, Kittur, Farooqahmed, Hung, Chiu-Yueh, Ding, Tomas

Get full text

Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats by Zhang, Hai-Qiang, Ding, Tomas T, Zhao, Jun-Sheng, Yang, Xin, Zhang, Hai-Xia, Zhang, Juan-Juan, Cui, Yun-Long

“…AIM： To evaluate the therapeutic effects of a probiotic supplement （Clostridium butyricum, CGMCC0313 ） in a chemically-induced rat model of experimental…”
Get full text

A plant-based mutant huntingtin model-driven discovery of impaired expression of GTPCH and DHFR by Hung, Chiu-Yueh, Zhu, Chuanshu, Kittur, Farooqahmed S., He, Maotao, Arning, Erland, Zhang, Jianhui, Johnson, Asia J., Jawa, Gurpreet S., Thomas, Michelle D., Ding, Tomas T., Xie, Jiahua

“…Pathophysiology associated with Huntington’s disease (HD) has been studied extensively in various cell and animal models since the 1993 discovery of the mutant…”
Get full text

Annular α-Synuclein Protofibrils Are Produced When Spherical Protofibrils Are Incubated in Solution or Bound to Brain-Derived Membranes by Ding, Tomas T, Lee, Seung-Jae, Rochet, Jean-Christophe, Lansbury, Peter T

“…The Parkinson's disease substantia nigra is characterized by the loss of dopaminergic neurons and the presence of cytoplasmic fibrillar Lewy bodies in…”
Get full text

Acceleration of Oligomerization, Not Fibrillization, Is a Shared Property of Both α -Synuclein Mutations Linked to Early-Onset Parkinson's Disease: Implications for Pathogenesis and Therapy by Conway, Kelly A., Lee, Seung-Jae, Rochet, Jean-Christophe, Ding, Tomas T., Williamson, Robin E., Lansbury, Peter T.

“…The Parkinson's disease (PD) substantia nigra is characterized by the presence of Lewy bodies containing fibrillar α -synuclein. Early-onset PD has been linked…”
Get full text

Dual-frequency ultrasound for designing two dimensional catalyst surface: Reduced graphene oxide–Pt composite by Vinodgopal, K., Neppolian, B., Salleh, Najah, Lightcap, Ian V., Grieser, Franz, Ashokkumar, Muthupandian, Ding, Tomas T., Kamat, Prashant V.

“…[Display omitted] ► Dual frequency ultrasound for synthesis of reduced graphene oxide (RGO)–Pt composites. ► Simultaneous reduction and exfoliation of graphene…”
Get full text

Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease by Volles, Michael J, Lee, Seung-Jae, Rochet, Jean-Christophe, Shtilerman, Mark D, Ding, Tomas T, Kessler, Jeffrey C, Lansbury, Peter T

“…Fibrillar α-synuclein is a component of the Lewy body, the characteristic neuronal inclusion of the Parkinson's disease (PD) brain. Both α-synuclein mutations…”
Get full text

Molecular Crowding Accelerates Fibrillization of α-Synuclein:  Could an Increase in the Cytoplasmic Protein Concentration Induce Parkinson's Disease? by Shtilerman, Mark D, Ding, Tomas T, Lansbury, Peter T

“…Parkinson's disease (PD) is one of many neurodegenerative diseases that are characterized by amyloid fibril formation. α-Synuclein is a primary component of…”
Get full text

Distinct second extracellular loop structures of the brain cannabinoid CB1 receptor: Implication in ligand binding and receptor function by Shim, Joong-Youn, Rudd, James, Ding, Tomas T.

“…The G‐protein‐coupled receptor (GPCR) second extracellular loop (E2) is known to play an important role in receptor structure and function. The brain…”
Get full text

Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease by Rochet, Jean-Christophe, Outeiro, Tiago Fleming, Conway, Kelly A, Ding, Tomas T, Volles, Michael J, Lashuel, Hilal A, Bieganski, Robert M, Lindquist, Susan L, Lansbury, Peter T

“…Parkinson's disease (PD) is a neurologic disorder resulting from the loss of dopaminergic neurons in the brain. Two lines of evidence suggest that the protein…”
Get full text

Distinct second extracellular loop structures of the brain cannabinoid CB sub(1) receptor: Implication in ligand binding and receptor function by Shim, Joong-Youn, Rudd, James, Ding, Tomas T

“…The G-protein-coupled receptor (GPCR) second extracellular loop (E2) is known to play an important role in receptor structure and function. The brain…”
Get full text

Distinct second extracellular loop structures of the brain cannabinoid CB 1 receptor: Implication in ligand binding and receptor function by Shim, Joong‐Youn, Rudd, James, Ding, Tomas T.

“…Abstract The G‐protein‐coupled receptor (GPCR) second extracellular loop (E2) is known to play an important role in receptor structure and function. The brain…”
Get full text

Distinct second extracellular loop structures of the brain cannabinoid CB(1) receptor: implication in ligand binding and receptor function by Shim, Joong-Youn, Rudd, James, Ding, Tomas T

“…The G-protein-coupled receptor (GPCR) second extracellular loop (E2) is known to play an important role in receptor structure and function. The brain…”
Get full text

Analysis of amyloid-beta assemblies using tapping mode atomic force microscopy under ambient conditions by Ding, T T, Harper, J D

Get more information

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for by Conway, Kelly A, Lee, Seung-Jae, Rochet, Jean-Christophe, Ding, Tomas T

“…The Parkinson's disease (PD) substantia nigra is characterized by the presence of Lewy bodies containing fibrillar alpha-synuclein. Early-onset PD has been…”
Get full text

Interactions among α-synuclein, dopamine, and biomembranes by Rochet Jean-Christophe, Fleming Outeiro Tiago, Conway, Kelly A, Ding, Tomas T, Volles, Michael J, Lashuel, Hilal A, Bieganski, Robert M, Lindquist, Susan L, Lansbury, Peter T

“…Parkinson’s disease (PD) is a neurologic disorder resulting from the loss of dopaminergic neurons in the brain. Two lines of evidence suggest that the protein…”
Get full text

Interactions among [alpha]-synuclein, dopamine, and biomembranes: Some clues for understanding neurodegeneration in parkinson's disease by Rochet, Jean-christophe, Fleming Outeiro, Tiago, Conway, Kelly A, Ding, Tomas T, Volles, Michael J, Lashuel, Hilal A, Bieganski, Robert M, Lindquist, Susan L, Lansbury, Peter T

“…Parkinson's disease (PD) is a neurologic disorder resulting from the loss of dopaminergic neurons in the brain. Two lines of evidence suggest that the protein…”
Get full text